[{"path":"/safety/recalls-market-withdrawals-safety-alerts/altaire-pharmaceuticals-inc-issues-voluntary-recall-multiple-ophthalmic-products-sold-ocusoft","field_change_date_2":"07/16/2019","field_brand_name":"<a href=\"/safety/recalls-market-withdrawals-safety-alerts/altaire-pharmaceuticals-inc-issues-voluntary-recall-multiple-ophthalmic-products-sold-ocusoft\">OCuSOFT</a>","field_product_description":" Prescription (RX) and Over-the-Counter (OTC) Ophthalmic products","field_recall_reason_description":" Due to lack of sterility assurance","field_recall_reason":"Potential Lack of Sterility","field_company_name":" Altaire Pharmaceuticals, Inc.,","field_product_type":"Generic Drugs, Prescription Drugs","term_node_tid":"Generic Drugs, Prescription Drugs","field_regulated_product_field":"Drugs","all-terms-rewrite":"Drugs, Generic Drugs, Prescription Drugs","publicationDate":"2019-07-16T04:00:00.000Z","link":"https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/altaire-pharmaceuticals-inc-issues-voluntary-recall-multiple-ophthalmic-products-sold-ocusoft","canonicalId":"91cebe6146e0264d565536ebb210fe97f342de4bc96293ec7fdc2b772a2c7750","title":"Altaire Pharmaceuticals, Inc. Issues Voluntary Recall of Multiple Ophthalmic Products Sold by OCuSOFT","description":"Altaire Pharmaceuticals, Inc., announces today that it is voluntarily recalling the Prescription (RX) and Over-the-Counter (OTC) drug products and lots, within expiry, sold by OCuSOFT during the time period as indicated in the tables below due to Quality Assurance.","feedName":"fda","feedSource":"fda","categories":[]},{"path":"/safety/recalls-market-withdrawals-safety-alerts/altaire-pharmaceuticals-inc-issues-voluntary-recall-multiple-ophthalmic-products-manufactured-and","field_change_date_2":"07/15/2019","field_brand_name":"<a href=\"/safety/recalls-market-withdrawals-safety-alerts/altaire-pharmaceuticals-inc-issues-voluntary-recall-multiple-ophthalmic-products-manufactured-and\">Altaire Pharmaceuticals, Inc.</a>","field_product_description":"OTC and Rx Ophthalmic Products","field_recall_reason_description":" Due to lack of sterility assurance","field_recall_reason":"Potential Lack of Sterility","field_company_name":"Altaire Pharmaceuticals Inc.","field_product_type":"","term_node_tid":"","field_regulated_product_field":"Drugs","all-terms-rewrite":"Drugs, ","publicationDate":"2019-07-15T04:00:00.000Z","link":"https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/altaire-pharmaceuticals-inc-issues-voluntary-recall-multiple-ophthalmic-products-manufactured-and","canonicalId":"43aaed68cf2edb80a79de2b988f7d849dc578a7eae69cc860663d6a52b80ba99","title":"Altaire Pharmaceuticals, Inc. Issues Voluntary Recall of Multiple Ophthalmic Products Manufactured and Distributed as Altaire Labeled Products","description":"Altaire Pharmaceuticals, Inc., announces today that it is voluntarily recalling the over the counter (OTC) and prescription (Rx)  drug products and lots, within expiry, it has manufactured and distributed under the Altaire label and trade dress during the time period as indicated below.","feedName":"fda","feedSource":"fda","categories":[]}]